• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Molecular mechanisms of T cell co-stimulation and co-inhibition.T 细胞共刺激和共抑制的分子机制。
Nat Rev Immunol. 2013 Apr;13(4):227-42. doi: 10.1038/nri3405. Epub 2013 Mar 8.
2
Mechanisms of costimulation.共刺激机制
Immunol Rev. 2009 May;229(1):5-11. doi: 10.1111/j.1600-065X.2009.00784.x.
3
T cell receptor signaling can directly enhance the avidity of CD28 ligand binding.T细胞受体信号传导可直接增强CD28配体结合的亲和力。
PLoS One. 2014 Feb 24;9(2):e89263. doi: 10.1371/journal.pone.0089263. eCollection 2014.
4
A costimulation-initiated signaling pathway regulates NFATc1 transcription in T lymphocytes.共刺激启动的信号通路调节T淋巴细胞中NFATc1的转录。
J Immunol. 2007 Jul 15;179(2):1096-103. doi: 10.4049/jimmunol.179.2.1096.
5
Yin-Yang of costimulation: crucial controls of immune tolerance and function.共刺激的阴阳学说:免疫耐受与功能的关键调控
Immunol Rev. 2009 May;229(1):88-100. doi: 10.1111/j.1600-065X.2009.00769.x.
6
Accessory Molecule and Costimulation Requirements for CD4 T Cell Response.CD4 T细胞应答的辅助分子及共刺激需求
Crit Rev Immunol. 2017;37(2-6):261-290. doi: 10.1615/CritRevImmunol.v37.i2-6.60.
7
Two pathways of costimulation through CD28.通过 CD28 的两条共刺激途径。
Immunol Res. 2009 Dec;45(2-3):159-72. doi: 10.1007/s12026-009-8097-6. Epub 2009 Feb 13.
8
B7-CD28 interaction is a late acting co-stimulatory signal for human T cell responses.B7与CD28的相互作用是人类T细胞反应的一种晚期起作用的共刺激信号。
Int Immunol. 1997 Aug;9(8):1095-102. doi: 10.1093/intimm/9.8.1095.
9
Costimulatory regulation of T cell function.T细胞功能的共刺激调节
Curr Opin Cell Biol. 1999 Apr;11(2):203-10. doi: 10.1016/s0955-0674(99)80027-1.
10
Regulation of NF-κB induction by TCR/CD28.TCR/CD28 调控 NF-κB 的诱导
Immunol Res. 2011 Aug;50(2-3):113-7. doi: 10.1007/s12026-011-8216-z.

引用本文的文献

1
From trash to treasure: tumor draining lymph nodes as a multi-omics goldmine in cancer therapy.从垃圾到宝藏:肿瘤引流淋巴结作为癌症治疗中的多组学金矿。
Front Oncol. 2025 Aug 19;15:1636942. doi: 10.3389/fonc.2025.1636942. eCollection 2025.
2
Cancer Immunotherapy in Combination with Radiotherapy and/or Chemotherapy: Mechanisms and Clinical Therapy.癌症免疫疗法与放疗和/或化疗联合应用:作用机制与临床治疗
MedComm (2020). 2025 Aug 31;6(9):e70346. doi: 10.1002/mco2.70346. eCollection 2025 Sep.
3
Precision nanotherapeutics for kidney disease: targeting inflammation and maladaptive repair.用于肾脏疾病的精准纳米疗法:靶向炎症和适应性不良修复
Int Urol Nephrol. 2025 Sep 3. doi: 10.1007/s11255-025-04714-9.
4
Inhibitory leukocyte immunoglobulin-like receptors, subfamily B (LILRBs) in human diseases: structure, roles, mechanisms, and clinical applications.人类疾病中的抑制性白细胞免疫球蛋白样受体B亚家族(LILRBs):结构、作用、机制及临床应用
Theranostics. 2025 Jul 25;15(16):8222-8258. doi: 10.7150/thno.116951. eCollection 2025.
5
Patients with peripheral artery disease demonstrate altered expression of soluble and membrane-bound immune checkpoints.外周动脉疾病患者表现出可溶性和膜结合免疫检查点的表达改变。
Front Immunol. 2025 Jul 21;16:1568431. doi: 10.3389/fimmu.2025.1568431. eCollection 2025.
6
Multiscale information processing in the immune system.免疫系统中的多尺度信息处理
Front Immunol. 2025 Jul 21;16:1563992. doi: 10.3389/fimmu.2025.1563992. eCollection 2025.
7
CAR T-cells meet autoimmune neurological diseases: a new dawn for therapy.嵌合抗原受体T细胞与自身免疫性神经疾病:治疗的新曙光
Front Immunol. 2025 Jul 18;16:1604174. doi: 10.3389/fimmu.2025.1604174. eCollection 2025.
8
Pan-cancer single cell transcriptomic clustering reveals heterogeneous CD8 exhausted T cell populations with different immune checkpoint inhibitor responses.泛癌单细胞转录组聚类揭示了具有不同免疫检查点抑制剂反应的异质性耗竭CD8 T细胞群体。
Oncoimmunology. 2025 Dec;14(1):2540504. doi: 10.1080/2162402X.2025.2540504. Epub 2025 Aug 3.
9
Microbiome dysbiosis and immune checkpoint inhibitors: Dual targets in Hepatocellular carcinoma management.微生物群失调与免疫检查点抑制剂:肝细胞癌治疗中的双重靶点
World J Hepatol. 2025 Jul 27;17(7):106810. doi: 10.4254/wjh.v17.i7.106810.
10
Immune Checkpoint Molecules in Hodgkin Lymphoma and Other Hematological Malignancies.霍奇金淋巴瘤及其他血液系统恶性肿瘤中的免疫检查点分子
Cancers (Basel). 2025 Jul 10;17(14):2292. doi: 10.3390/cancers17142292.

本文引用的文献

1
Immunobiology. Combined targeted and immunotherapy: the future of personalized medicine.免疫生物学。联合靶向治疗和免疫治疗:个性化医学的未来。
Blood. 2012 Nov 29;120(23):4454-5. doi: 10.1182/blood-2012-09-455105.
2
Network analysis reveals centrally connected genes and pathways involved in CD8+ T cell exhaustion versus memory.网络分析揭示了 CD8+ T 细胞耗竭与记忆相关的中枢连接基因和途径。
Immunity. 2012 Dec 14;37(6):1130-44. doi: 10.1016/j.immuni.2012.08.021. Epub 2012 Nov 15.
3
MODULATING CO-STIMULATION DURING ANTIGEN PRESENTATION TO ENHANCE CANCER IMMUNOTHERAPY.在抗原呈递过程中调节共刺激以增强癌症免疫疗法
Immunol Endocr Metab Agents Med Chem. 2012 Sep;12(3):224-235. doi: 10.2174/187152212802001875.
4
Functional exhaustion of CD4+ T lymphocytes during primary cytomegalovirus infection.原发性巨细胞病毒感染期间 CD4+T 淋巴细胞功能耗竭。
J Immunol. 2012 Sep 1;189(5):2665-72. doi: 10.4049/jimmunol.1101165. Epub 2012 Aug 3.
5
Bat3 promotes T cell responses and autoimmunity by repressing Tim-3–mediated cell death and exhaustion.Bat3 通过抑制 Tim-3 介导的细胞死亡和衰竭来促进 T 细胞反应和自身免疫。
Nat Med. 2012 Sep;18(9):1394-400. doi: 10.1038/nm.2871.
6
OX40 signaling favors the induction of T(H)9 cells and airway inflammation.OX40 信号转导有利于诱导 T(H)9 细胞和气道炎症。
Nat Immunol. 2012 Oct;13(10):981-90. doi: 10.1038/ni.2390. Epub 2012 Jul 29.
7
HVEM signalling at mucosal barriers provides host defence against pathogenic bacteria.HVEM 信号在黏膜屏障处提供宿主防御以对抗病原性细菌。
Nature. 2012 Aug 9;488(7410):222-5. doi: 10.1038/nature11242.
8
An improved understanding of TNFL/TNFR interactions using structure-based classifications.利用基于结构的分类方法,提高对 TNFL/TNFR 相互作用的理解。
Trends Biochem Sci. 2012 Sep;37(9):353-63. doi: 10.1016/j.tibs.2012.06.002. Epub 2012 Jul 11.
9
Combating chronic T-cell exhaustion.对抗慢性T细胞耗竭。
Immunotherapy. 2012 Jun;4(6):557-60. doi: 10.2217/imt.12.46.
10
Selective effects of PD-1 on Akt and Ras pathways regulate molecular components of the cell cycle and inhibit T cell proliferation.PD-1 对 Akt 和 Ras 通路的选择性作用调节细胞周期的分子成分并抑制 T 细胞增殖。
Sci Signal. 2012 Jun 26;5(230):ra46. doi: 10.1126/scisignal.2002796.

T 细胞共刺激和共抑制的分子机制。

Molecular mechanisms of T cell co-stimulation and co-inhibition.

机构信息

Department of Immunobiology and Yale Cancer Center, Yale University School of Medicine, New Haven, Connecticut 06519, USA.

出版信息

Nat Rev Immunol. 2013 Apr;13(4):227-42. doi: 10.1038/nri3405. Epub 2013 Mar 8.

DOI:10.1038/nri3405
PMID:23470321
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3786574/
Abstract

Co-stimulatory and co-inhibitory receptors have a pivotal role in T cell biology, as they determine the functional outcome of T cell receptor (TCR) signalling. The classic definition of T cell co-stimulation continues to evolve through the identification of new co-stimulatory and co-inhibitory receptors, the biochemical characterization of their downstream signalling events and the delineation of their immunological functions. Notably, it has been recently appreciated that co-stimulatory and co-inhibitory receptors display great diversity in expression, structure and function, and that their functions are largely context dependent. Here, we focus on some of these emerging concepts and review the mechanisms through which T cell activation, differentiation and function is controlled by co-stimulatory and co-inhibitory receptors.

摘要

共刺激和共抑制受体在 T 细胞生物学中起着关键作用,因为它们决定了 T 细胞受体 (TCR) 信号的功能结果。随着新的共刺激和共抑制受体的鉴定、其下游信号事件的生化特征以及免疫功能的阐明,T 细胞共刺激的经典定义不断发展。值得注意的是,最近人们认识到,共刺激和共抑制受体在表达、结构和功能上具有很大的多样性,它们的功能在很大程度上取决于上下文。在这里,我们关注其中的一些新出现的概念,并回顾共刺激和共抑制受体控制 T 细胞激活、分化和功能的机制。